Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.51 +1.72 (+1.47%)
Streaming Delayed Price Updated: 2:01 PM EST, Jan 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
36 37 Next >
A Bearish Sign Appears On Abbott Laboratories's Chart
If history is any guide, there may be trouble ahead for shares of Abbott Laboratories (NYSE:ABT). A so-called "death cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia
Eli Lilly And Co (NYSE: LLY) said it would continue to supply drugs to Russia for urgent medical conditions such as cancer and diabetes but will suspend sales of "non-essential medicines." 
Via Benzinga
CNBC's Final Trades: Interactive Brokers, Abbott Laboratories, Apple And This REIT Stock
On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners chose Interactive Brokers Group, Inc. (NASDAQ: IBKR) as his top pick. 
Via Benzinga
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 3.32% on an annualized basis. Buying $1,000 In ABT: 10 years ago, an investor could have... 
Via Benzinga
10 More Major US Corporations Still Doing Business In Russia
The flow of U.S. companies exiting Russia has intensified as President Vladimir Putin’s military continues to lay waste to Ukraine. But while more than 300 major companies... 
Via Benzinga
4 Stocks With A Perfect Dividend Triangle
Today, we present 4 stocks with a perfect dividend triangle to illustrate how it leads to robust companies. 
Via Talk Markets
Dividend Kings In Focus: AbbVie
A look at AbbVie’s business model, growth potential, and why we rate the stock as a buy for dividend growth investors. 
Via Talk Markets
Abbott Labs Crushes Quarterly Views On Strong Covid Tests, But Shares Fall On Weak Outlook
Abbott reported $2.3 billion in Covid testing sales for the fourth quarter. 
Via Investor's Business Daily
Dividend Income Update February 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolios. 
Via Talk Markets
7 Long-Term Stocks to Buy Now and Hold Forever
Here are seven long-term stocks that fit well in most investors' portfolios as core holdings over decades, at least historically speaking. 7 Long-Term Stocks to Buy Now and Hold Forever 
Via InvestorPlace
36 Stocks To Watch After Biden's First State of The Union Address
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped... 
Via Benzinga
Abbott's CardioMEMS HF System Scores FDA Nod For Earlier-Stage Heart Failure
The FDA has approved an expanded indication for Abbott Laboratories' (NYSE: ABT) CardioMEMS HF System. The CardioMEMS HF System was initially... 
Via Benzinga
Half The American Population May Suffer From Chronic Illnesses By 2025, According To This Report
Photo by Towfiqu barbhuiya on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. If you think the... 
Via Benzinga
Abbott Labs Outlook Cools the Omicron Led Testing Boom
Photo by Adam Nieścioruk on Unsplash 
Via Benzinga
Stock Market Whipsaws Lower On Hawkish Fed, Tesla; Apple, Microsoft Earnings Strong: Weekly Review
Microsoft and Apple earnings were strong, but the correction is getting worse. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Abbott Laboratories
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Abbott Laboratories Whale Trades For January 26
Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position... 
Via Benzinga
Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook
Abbott Laboratories (NYSE: ABT) has reported Q4 FY21 adjusted EPS of $1.32, down from $1.45 a year ago but better than the consensus of $1.21. Q4 sales of $11.5... 
Via Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Recap: Abbott Laboratories Q4 Earnings
Abbott Laboratories (NYSE:ABT) reported its Q4 earnings results on Wednesday, January 26, 2022 at 07:30 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Gain; Fed Policy Decision In Focus
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of policy decision from the Federal Reserve. The Nasdaq index dropped by more than 300 points on... 
Via Benzinga
7 Stocks To Watch For January 26, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects AT&T Inc. (NYSE: T) to report quarterly earnings at $0.76 per share on revenue of $40.43... 
Via Benzinga
A Preview Of Abbott Laboratories's Earnings
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that... 
Via Talk Markets
Earnings Scheduled For January 26, 2022
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to... 
Via Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the... 
Via Benzinga
Price Over Earnings Overview: Abbott Laboratories
Right now, Abbott Laboratories Inc. (NYSE:ABT) share price is at $126.19, after a 1.1% gain. Moreover, over the past month, the stock fell by 10.80%, but in the past... 
Via Benzinga
CNBC's Final Trades: Abbott Laboratories, Starbucks, Bank of America And This Financial Services Stock
On CNBC’s “Halftime Report... 
Via Benzinga
3 Dividend Aristocrats Yielding Over 4%
When looking for great dividend stocks, start with the Dividend Aristocrats. These companies have stood the test of time. 
Via InvestorPlace
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.